Paul Deutsch

Paul Deutsch currently serves as Principal at Deutsch Biopharma Consulting and Advisory Partner at Ascenta Capital, both positions held since October 2023. Prior to these roles, Paul Deutsch worked at Sanofi from December 2005 to October 2023, where responsibilities included serving as SVP and Global Head of Translational Medicine and Early Development, with a focus on precision medicine. Paul Deutsch's extensive experience in clinical pharmacology includes roles at Merck from 1992 to 2005, where various positions culminated in Executive Director of Clinical Pharmacology, Oncology, and Molecular Profiling. Additionally, Paul Deutsch held an academic role as Assistant Professor at Weill Cornell Medical College from 1988 to 1992. Educational credentials include an MD PhD in Medicine and Pharmacology from Albert Einstein College of Medicine and an AB in Biochemical Sciences from Harvard College.